3.4 Other Toxicities
Treatment related adverse events (TRAEs) that occurred in >10% of patients are shown in Table 2 . All patients experienced some degree of anemia, lymphopenia, neutropenia, thrombocytopenia, leukopenia and nausea. Other common TRAEs included sinus tachycardia (83%), fatigue (83%), increased alanine aminotransferase (75%), anorexia (75%), vomiting (67%), increased alkaline phosphatase (67%) and hypertension (67%).